Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis

Abstract

BACKGROUND Currently available antifibrotic treatments may slow down disease progression in idiopathic pulmonary fibrosis (IPF), but are associated with potentially significant side effects and are costly. Mycophenolate mofetil (MMF) is well known for its potent immunosuppressive properties and possesses important antiproliferative and antifibrotic effects… (More)
DOI: 10.1371/journal.pone.0176312

Topics

7 Figures and Tables

Slides referencing similar topics